1-stearoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycerol

Metabolite details

Identifier

LBDXVTOFXXDOGH-KXYFHQNYSA-N

InChI Key

LBDXVTOFXXDOGH-KXYFHQNYSA-N

IUPAC name

(2S)-1-hydroxy-3-(octadecanoyloxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

Preferred name

1-stearoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycerol

INN name

—

Synonym

(2S)-1-hydroxy-3-(stearoyloxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

ChEBI

CHEBI:77129

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• 4-Octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• Wild_type_vs_hfq
• non_COVID_19_healthy_vs_non_critical_COVID_19
• Control_vs_AONFH_Stage_III_IV
• G1_Control_vs_G2_Arginine_Addition
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Control_vs_DMXAA16h
• wild_type_vs_patA_deletion